Related Experiment Video
Updated: Jul 15, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Gene therapy: role in myocardial protection
A S Pachori1, L G Melo, V J Dzau
1Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27701, USA. alok.pachori@duke.edu
Handbook of Experimental Pharmacology
|September 27, 2006
Summary
Gene therapy offers new hope for heart failure patients. Advances in gene delivery vectors are enabling novel treatments for myocardial protection, with viral-based therapies progressing to clinical trials for cardiovascular diseases.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Genetics
Background:
- Heart failure (HF) linked to coronary artery disease (CAD) significantly impacts morbidity and mortality.
- Understanding HF molecular mechanisms reveals novel therapeutic targets.
- Gene delivery vectors provide a platform for myocardial protection strategies.
Purpose of the Study:
- To review recent advancements in gene therapy for heart failure (HF).
- To discuss the clinical applications of gene therapy in cardiovascular diseases.
- To highlight the potential of gene therapy in treating HF associated with CAD.
Main Methods:
- Review of current literature on gene therapy for cardiovascular diseases.
- Focus on viral-based gene delivery systems.
- Analysis of experimental and clinical trial data for HF gene therapy.
Main Results:
- Viral-based gene therapies show promise for complex cardiovascular conditions like myocardial ischemia and hypertension.
- Several experimental gene therapies are in clinical evaluation for cardiovascular diseases.
- Gene therapy offers a promising avenue for myocardial protection in HF patients.
Conclusions:
- Gene therapy represents a significant advancement in treating heart failure.
- The combination of molecular insights and efficient gene vectors facilitates novel therapeutic approaches.
- Clinical translation of gene therapy holds potential for improving outcomes in cardiovascular disease patients.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...